title: Levetiracetam for agitated Alzheimer's disease patients.
authors.forename: Myron F
authors.initials: MF
authors.lastname: Weiner
authors.forename: Kyle B
authors.initials: KB
authors.lastname: Womack
authors.forename: Kristin
authors.initials: K
authors.lastname: Martin-Cook
authors.forename: Doris A
authors.initials: DA
authors.lastname: Svetlik
authors.forename: Linda S
authors.initials: LS
authors.lastname: Hynan
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000188:drug therapy*; D001519:Behavior / Q000187:drug effects*; D003071:Cognition / Q000187:drug effects*; D005260:Female; D006801:Humans; D007398:Interpersonal Relations; D000077287:Levetiracetam; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D018697:Nootropic Agents / Q000627:therapeutic use*; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D018697:Nootropic Agents; D000077287:Levetiracetam; D010889:Piracetam